ipilimumab
bms
['lung']
at our team is fully ready for cell therapy in lung cancers. we currently participate to the only tils trial open in and we are the unique site open.
conversingly, last tuesday we performed the first procurement in this trial #esmo22 
Head of pulmonology unit @pneumo_LS @CHUdeLyon
Professor of Pulmonology @UnivLyon1
Scientific head @URCOT_lyon & @IFCTlung
#liquidbiopsy~#screening~????